PMQR genes oqxAB and aac(6')Ib-cr accelerate the development of fluoroquinolone resistance in salmonella Typhimurium

Frontiers in Microbiology

Volumn 5, Issue SEP, 2014, Pages

  Wong, Marcus Ho Yin ^a   Chan, Edward Wai Chi ^b   Liu, Li Zhang ^a   Chen, Sheng ^a  

^a HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Aac(6')Ib cr; Acssut R type; Ciprofloxacin resistance; OqxAB; S.Typhimurium

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; NALIDIXIC ACID; OLAQUINDOX; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SODIUM AZIDE; STREPTOMYCIN; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM;

AAC(6 )IB CR GENE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM CONJUGATION; BACTERIUM ISOLATE; CONCENTRATION (PARAMETERS); DRUG TARGETING; ESCHERICHIA COLI; GENE; GENE LOCATION; GENE MUTATION; GENE TRANSFER; HYBRIDIZATION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MUTATION PREVENTION CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OQXAB GENE; PLASMID; PLASMID MEDIATED QUINOLONE RESISTANCE; POLYMERASE CHAIN REACTION; SALMONELLA TYPHIMURIUM;

SALMONELLA; SALMONELLA TYPHIMURIUM;

EID: 84907676724     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00521     Document Type: Article

References (33)

1. Gomez TM, Motarjemi Y, Miyagawa S, Kaferstein FK, Stohr K. Foodborne salmonellosis. World health statistics quarterly Rapport trimestriel de statistiques sanitaires mondiales. 1997; 50(1-2): 81-9.
2. Hohmann EL. Nontyphoidal salmonellosis. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2001; 32(2): 263-9.
3. Centers for Disease C, Prevention. Multidrug-resistant Salmonella serotype Typhimurium--United States, 1996. MMWR Morbidity and mortality weekly report. 1997; 46(14): 308-10.
4. Markogiannakis A, Tassios PT, Lambiri M, Ward LR, Kourea-Kremastinou J, Legakis NJ, et al. Multiple clones within multidrug-resistant Salmonella enterica serotype Typhimurium phage type DT104. The Greek Nontyphoidal Salmonella Study Group. Journal of clinical microbiology. 2000; 38(3): 1269-71.
5. Glynn MK, Bopp C, Dewitt W, Dabney P, Mokhtar M, Angulo FJ. Emergence of multidrug resistant Salmonella enterica serotype typhimurium DT104 infections in the United States. The New England journal of medicine. 1998; 338(19): 1333-8.
6. Hawkey PM. Mechanisms of quinolone action and microbial response. The Journal of antimicrobial chemotherapy. 2003; 51 Suppl 1: 29-35.
7. Tran JH, Jacoby GA, Hooper DC. Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrob Agents Chemother. 2005; 49(1): 118-25.
8. Yamane K, Wachino J, Suzuki S, Kimura K, Shibata N, Kato H, et al. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob Agents Chemother. 2007; 51(9): 3354-60.
9. Robicsek A, Strahilevitz J, Jacoby GA, Macielag M, Abbanat D, Park CH, et al. Fluoroquinolone modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nature medicine. 2006; 12(1): 83-8.
10. Cattoir V, Nordmann P. Plasmid-mediated quinolone resistance in gram-negative bacterial species: an update. Curr Med Chem. 2009; 16(8): 1028-46.
11. Hansen LH, Jensen LB, Sorensen HI, Sorensen SJ. Substrate specificity of the OqxAB multidrug resistance pump in Escherichia coli and selected enteric bacteria. The Journal of antimicrobial chemotherapy. 2007; 60(1): 145-7.
12. Hansen LH, Johannesen E, Burmolle M, Sorensen AH, Sorensen SJ. Plasmid-encoded multidrug efflux pump conferring resistance to olaquindox in Escherichia coli. Antimicrobial agents and chemotherapy. 2004; 48(9): 3332-7.
13. Wong MH, Chen S. First detection of oqxAB in Salmonella spp. isolated from food. Antimicrobial agents and chemotherapy. 2012.
14. Liu BT, Wang XM, Liao XP, Sun J, Zhu HQ, Chen XY, et al. Plasmid-mediated quinolone resistance determinants oqxAB and aac(6')-Ib-cr and extended-spectrum beta-lactamase gene blaCTX-M-24 co-located on the same plasmid in one Escherichia coli strain from China. The Journal of antimicrobial chemotherapy. 2011; 66(7): 1638-9.
15. Zhao J, Chen Z, Chen S, Deng Y, Liu Y, Tian W, et al. Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment. Antimicrob Agents Chemother. 2010; 54(10): 4219-24.
16. Yuan J, Xu X, Guo Q, Zhao X, Ye X, Guo Y, et al. Prevalence of the oqxAB gene complex in Klebsiella pneumoniae and Escherichia coli clinical isolates. J Antimicrob Chemother. 2012; 67(7): 1655-9.
17. Ruiz E, Saenz Y, Zarazaga M, Rocha-Gracia R, Martinez-Martinez L, Arlet G, et al. qnr, aac(6')-Ib-cr and qepA genes in Escherichia coli and Klebsiella spp.: genetic environments and plasmid and chromosomal location. The Journal of antimicrobial chemotherapy. 2012; 67(4): 886-97.
18. Park KS, Kim MH, Park TS, Nam YS, Lee HJ, Suh JT. Prevalence of the plasmid-mediated quinolone resistance genes, aac(6')-Ib-cr, qepA, and oqxAB in clinical isolates of extended-spectrum beta lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae in Korea. Annals of clinical and laboratory science. 2012; 42(2): 191-7.
19. Kim HB, Wang M, Park CH, Kim EC, Jacoby GA, Hooper DC. oqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae. Antimicrob Agents Chemother. 2009; 53(8): 3582-4.
20. Kim JH, Cho JK, Kim KS. Prevalence and characterization of plasmid-mediated quinolone resistance genes in Salmonella isolated from poultry in Korea. Avian Pathol. 2013.
21. Cavaco LM, Hasman H, Xia S, Aarestrup FM. qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin. Antimicrobial agents and chemotherapy. 2009; 53(2): 603-8.
22. Ferrari R, Galiana A, Cremades R, Rodriguez JC, Magnani M, Tognim MC, et al. Plasmid mediated quinolone resistance by genes qnrA1 and qnrB19 in Salmonella strains isolated in Brazil. J Infect Dev Ctries. 2011; 5(6): 496-8.
23. Wong MH, Yan M, Chan EW, Liu LZ, Kan B, Chen S. Expansion of Salmonella Typhimurium ST34 clone carrying multiple resistance determinants in China. Antimicrobial agents and chemotherapy. 2013.
24. Chen S, Cui S, McDermott PF, Zhao S, White DG, Paulsen I, et al. Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials. Antimicrob Agents Chemother. 2007; 51(2): 535-42.
25. Jacoby GA, Chow N, Waites KB. Prevalence of plasmid-mediated quinolone resistance. Antimicrob Agents Chemother. 2003; 47(2): 559-62.
26. Sato T, Yokota S, Uchida I, Okubo T, Usui M, Kusumoto M, et al. Fluoroquinolone resistance mechanisms in an Escherichia coli isolate, HUE1, without quinolone resistance-determining region mutations. Frontiers in microbiology. 2013; 4: 125.
27. Gebru E, Damte D, Choi MJ, Lee SJ, Kim YH, Park SC. Mutant prevention concentration and phenotypic and molecular basis of fluoroquinolone resistance in clinical isolates and in vitro-selected mutants of Escherichia coli from dogs. Veterinary microbiology. 2012; 154(3-4): 384-94.
28. Gebru E, Choi MJ, Lee SJ, Damte D, Park SC. Mutant-prevention concentration and mechanism of resistance in clinical isolates and enrofloxacin/marbofloxacin-selected mutants of Escherichia coli of canine origin. Journal of medical microbiology. 2011; 60(Pt 10): 1512-22.
29. Norman A, Hansen LH, She Q, Sorensen SJ. Nucleotide sequence of pOLA52: a conjugative IncX1 plasmid from Escherichia coli which enables biofilm formation and multidrug efflux. Plasmid. 2008; 60(1): 59-74.
30. Fung DK, Chan EW, Chin ML, Chan RC. Delineation of a bacterial starvation stress response network which can mediate antibiotic tolerance development. Antimicrobial agents and chemotherapy. 2010; 54(3): 1082-93.
31. Chu C, Su LH, Chu CH, Baucheron S, Cloeckaert A, Chiu CH. Resistance to fluoroquinolones linked to gyrA and par C mutations and overexpression of acr AB efflux pump in Salmonella enterica serotype Choleraesuis. Microb Drug Resist. 2005; 11(3): 248-53.
32. Casin I, Breuil J, Darchis JP, Guelpa C, Collatz E. Fluoroquinolone resistance linked to GyrA, GyrB, and ParC mutations in Salmonella enterica typhimurium isolates in humans. Emerging infectious diseases. 2003; 9(11): 1455-7.
33. Wong MH, Yan M, Chan EW, Biao K, Chen S. Emergence of Clinical Salmonella Typhimurium with Concurrent Resistant to Ciprofloxacin, Ceftriaxone and Azithromycin. Antimicrobial agents and chemotherapy. 2014.